Nine months ago, I published a piece positioning CIRCA-CLEAR as a complement to Cynefin—arguing that while Cynefin maps the terrain, CIRCA senses the turbulence. Check out the original post Beyond Cynefin: How CIRCA Helps Leaders Make Sense of Today’s Complexity The response was thoughtful. But the ground has shifted again. And this time, it’s teaching … Read more
The question isn’t whether you’re changing. It’s whether you’re changing fast enough. The manuscript hit 150,000 words before I stopped counting. Too big. A motivated leader doesn’t have time for a 600-page read. They need something they can finish in a single sitting and apply on Monday. So I cut it. Ruthlessly. Down to around … Read more
Your work spans three spaces—doing deep design, leading design teams, and amplifying design thinking. But they all collide on the same problem: the system around you is becoming more turbulent, not less capable. You’re being asked to hold outcomes steady while the organisation becomes more political, more interdependent, more contradictory. Priorities that contradict each other … Read more
What 15 years of ground-level observation reveals about DSO’s real trajectory BOTTOM LINE Published metrics tell one story. Ground-level observation tells another. I’ve watched Bayer’s evolution for over 15 years—close enough to see patterns that analyst reports miss. The signals that predict transformation success or failure aren’t in quarterly earnings. They’re in who stays, who … Read more
Thriving in Turbulence is live on Amazon. Here’s the diagnostic system behind it. Monday morning. Your transformation is three months in. Everyone’s working harder than ever. Standups happen. Retrospectives are religious. You’ve got OKRs, Kanban boards, and detailed roadmaps. Yet delivery is slowing. Dependencies multiply. Your best people look exhausted. Stakeholders escalate to your boss. … Read more
Precedents, patterns, and why scale changes everything BOTTOM LINE The largest Western self-management experiment before Bayer was Zappos. They had 8 years as “best place to work,” 1,500 employees, and voluntary departures. They still quietly retreated from holacracy. Bayer has 60× the scale, a trust deficit, and involuntary layoffs. The precedent doesn’t predict failure—but it … Read more